PFE
輝瑞 PFIZER INC
+0.27 (+0.98%)27.73USD8.9M成交股數158B市值36.5本益比(近四季)2.5股價營收比+2.6%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 15.0B+3% | 14.5B+5% | 17.6B-1% | 16.7B+25% | 14.7B-2% | 13.7B+131% | 17.7B+31% | 13.3B+2% | 14.9B | 5.9B | 13.5B | 13.0B |
| 營業成本 | 4.1B | 3.5B | 5.3B | 4.2B | 3.8B | 2.8B | 5.3B | 3.3B | 3.4B | 7.6B | 9.3B | 3.2B |
| 毛利 | 10.9B+1% | 10.9B+0% | 12.3B-1% | 12.5B+25% | 10.9B-5% | 10.9B-766% | 12.4B+195% | 10.0B+2% | 11.5B | −1.6B | 4.2B | 9.8B |
| 毛利率 | 72.8% | 75.4% | 70.0% | 74.9% | 74.2% | 79.3% | 70.3% | 75.2% | 77.3% | -27.5% | 31.3% | 75.1% |
| 研發費用 | 2.8B | 2.5B | 3.2B | 2.5B | 2.5B | 2.2B | 2.6B | 2.7B | 2.5B | 2.8B | 2.7B | 2.6B |
| 銷售管理費用 | 3.4B | 3.0B | 4.2B | 3.2B | 3.4B | 3.0B | 3.2B | 3.7B | 3.5B | 4.6B | 3.3B | 3.5B |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −248M-109% | 2.7B-9% | −1.6B-137% | 3.5B+8537% | 2.9B-7% | 3.0B-188% | 4.5B-287% | 41.0M-98% | 3.1B | −3.4B | −2.4B | 2.3B |
| 淨利率 | -1.6% | 18.6% | -9.4% | 21.3% | 19.9% | 21.6% | 25.2% | 0.3% | 20.9% | -56.8% | -17.7% | 17.9% |
| 稀釋 EPS | -0.04-108% | 0.47-10% | -0.29-137% | 0.62+6100% | 0.51-7% | 0.52-188% | 0.78-286% | 0.01-98% | 0.55 | -0.59 | -0.42 | 0.41 |
| 稀釋股數 | 5.70B | 5.73B | 5.71B | 5.71B | 5.71B | 5.71B | 5.71B | 5.70B | 5.70B | 5.71B | 5.65B | 5.71B |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 976M | 1.7B | 1.1B | 1.3B | 1.6B | 1.4B | 1.1B | 1.1B | 719M | 2.9B | 3.1B | 2.6B |
| 應收帳款 | 12.5B | 12.6B | 11.9B | 14.3B | 12.1B | 11.8B | 14.5B | 11.4B | 11.0B | 11.6B | 11.1B | 10.2B |
| 存貨 | 9.9B | 10.7B | 10.7B | 11.5B | 11.7B | 10.9B | 11.7B | 11.4B | 10.9B | 10.2B | 10.2B | 10.3B |
| 總資產 | 201B | 208B | 208B | 209B | 206B | 208B | 219B | 216B | 221B | 227B | 215B | 220B |
| 有息負債 | 60.5B | 60.6B | 61.6B | 57.4B | 57.5B | 57.6B | 58.0B | 57.5B | 61.3B | 61.5B | 61.0B | 61.4B |
| 總負債 | 116B | 117B | 121B | 116B | 117B | 117B | 127B | 128B | 129B | 137B | 118B | 121B |
| 股東權益 | 85.2B | 90.1B | 86.5B | 92.8B | 88.7B | 90.3B | 92.3B | 87.7B | 92.3B | 89.0B | 96.9B | 99.0B |
| 負債比 | 57.5% | 56.5% | 58.3% | 55.4% | 56.8% | 56.4% | 57.8% | 59.3% | 58.1% | 60.6% | 54.8% | 54.9% |
| 淨現金(現金 − 有息負債) | −59.5B | −58.9B | −60.5B | −56.1B | −55.9B | −56.2B | −56.9B | −56.5B | −60.6B | −58.7B | −57.9B | −58.7B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 2.6B+12% | – | – | – | 2.3B | – | – | 1.1B | – | – | – |
| 資本支出 | – | 436M | – | – | – | 564M | – | – | 704M | – | – | – |
| 自由現金流 | – | 2.2B+23% | – | – | – | 1.8B | – | – | 386M | – | – | – |
| 折舊攤銷 | 1.6B | 1.6B | 1.7B | 1.7B | 1.6B | 1.6B | 1.8B | 1.7B | 1.7B | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 15.1% | – | – | – | 12.9% | – | – | 2.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 61.2B
| Biopharma | 61.2B | 100.0% | -1.9% |
|---|
地區2025 年度 · 62.6B
| 美國 | 37.1B | 59.2% | -4.2% |
|---|---|---|---|
| International Developed Markets | 16.2B | 25.9% | +0.8% |
| International Emerging Markets | 9.3B | 14.9% | +4.9% |
產品／服務2025 年度 · 53.3B
| 產品 | 51.7B | 96.9% | -4.0% |
|---|---|---|---|
| Royalty | 1.7B | 3.1% | +16.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 62.6B | -1.6% | 7.8B | 12.4% | 1.36 | 9.1B |
| FY2024 | 63.6B | +25.0% | 8.0B | 12.6% | 1.41 | 9.8B |
| FY2023 | 50.9B | -44.5% | 2.1B | 4.2% | 0.37 | 4.8B |
| FY2022 | 91.8B | +24.7% | 31.4B | 34.2% | 5.47 | 26.0B |
| FY2021 | 73.6B | +76.8% | 22.0B | 29.8% | 3.85 | 29.9B |
| FY2020 | 41.7B | +1.8% | 9.2B | 22.0% | 1.63 | 12.2B |
| FY2019 | 40.9B | +0.2% | 16.0B | 39.2% | 2.82 | 10.5B |
| FY2018 | 40.8B | – | 11.2B | 27.3% | 1.87 | 13.8B |